Drugs and Devices

FDA recommends removing Avastin’s breast cancer indication

The U.S. Food and Drug Administration (FDA) is recommending that the breast cancer indication for Avastin be removed from its label “because the drug has not been shown to be safe and effective for that use.” Read more here.


Related Articles:

Leave a Reply

Your email address will not be published. Required fields are marked *

 

Shares